Ji-Hwan Hwang Selected Research

JBIR-23

1/2011	Induction of tubulin polymerization and apoptosis in malignant mesothelioma cells by a new compound JBIR-23.
1/2009	JBIR-23 and -24, novel anticancer agents from Streptomyces sp. AK-AB27.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ji-Hwan Hwang Research Topics

Disease

7	Neoplasms (Cancer) 04/2012 - 04/2006
4	Colonic Neoplasms (Colon Cancer) 07/2010 - 01/2007
4	Carcinoma (Carcinomatosis) 04/2008 - 04/2006
2	Malignant Mesothelioma 01/2011 - 01/2009
2	Hypoxia (Hypoxemia) 07/2010 - 11/2007
1	Starvation 07/2010
1	AIDS-Related Complex (ARC) 07/2010

Drug/Important Bio-Agent (IBA)

5	Glucose (Dextrose)FDA LinkGeneric 07/2010 - 04/2006
4	Endoplasmic Reticulum Chaperone BiPIBA 07/2010 - 04/2006
3	Antineoplastic Agents (Antineoplastics)IBA 07/2010 - 11/2007
2	JBIR-23IBA 01/2011 - 01/2009
2	Etoposide (VP 16)FDA LinkGeneric 04/2008 - 11/2007
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2007 - 04/2006
1	TubulinIBA 01/2011
1	Eukaryotic Initiation Factor-2 (EIF 2)IBA 07/2010
1	arctigeninIBA 07/2010
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 07/2010
1	Caspase 9IBA 07/2010
1	furanIBA 01/2009
1	piericidin AIBA 04/2008
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 11/2007
1	trioctyl phosphine oxide (TOPO)IBA 11/2007
1	Plicamycin FDA Link 11/2007
1	thiazolyl blueIBA 09/2007
1	CaspasesIBA 09/2007
1	verrucosidinIBA 01/2007
1	ValinomycinIBA 04/2006

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 09/2007 - 04/2006
1	Therapeutics 04/2012